Axe Compute Total Assets 2012-2025 | AGPU
Axe Compute total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
|
Axe Compute Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $5 |
| 2023 | $14 |
| 2022 | $26 |
| 2021 | $44 |
| 2020 | $13 |
| 2019 | $22 |
| 2018 | $4 |
| 2017 | $4 |
| 2016 | $3 |
| 2015 | $6 |
| 2014 | $1 |
| 2013 | $1 |
| 2012 | $0 |
| 2011 | $0 |
|
Axe Compute Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-09-30 | $3 |
| 2025-06-30 | $3 |
| 2025-03-31 | $6 |
| 2024-12-31 | $5 |
| 2024-09-30 | $7 |
| 2024-06-30 | $11 |
| 2024-03-31 | $11 |
| 2023-12-31 | $14 |
| 2023-09-30 | $18 |
| 2023-06-30 | $21 |
| 2023-03-31 | $25 |
| 2022-12-31 | $26 |
| 2022-09-30 | $33 |
| 2022-06-30 | $36 |
| 2022-03-31 | $40 |
| 2021-12-31 | $44 |
| 2021-09-30 | $51 |
| 2021-06-30 | $57 |
| 2021-03-31 | $40 |
| 2020-12-31 | $13 |
| 2020-09-30 | $25 |
| 2020-06-30 | $27 |
| 2020-03-31 | $25 |
| 2019-12-31 | $22 |
| 2019-09-30 | $32 |
| 2019-06-30 | $32 |
| 2019-03-31 | $5 |
| 2018-12-31 | $4 |
| 2018-09-30 | $5 |
| 2018-06-30 | $4 |
| 2018-03-31 | $6 |
| 2017-12-31 | $4 |
| 2017-09-30 | $3 |
| 2017-06-30 | $5 |
| 2017-03-31 | $5 |
| 2016-12-31 | $3 |
| 2016-09-30 | $2 |
| 2016-06-30 | $3 |
| 2016-03-31 | $4 |
| 2015-12-31 | $6 |
| 2015-09-30 | $8 |
| 2015-06-30 | $1 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $1 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $1 |
| 2013-09-30 | $1 |
| 2013-06-30 | $0 |
| 2013-03-31 | $1 |
| 2012-12-31 | $0 |
| 2012-09-30 | $0 |
| 2012-06-30 | $0 |
| 2012-03-31 | $0 |
| 2011-12-31 | $0 |
| 2011-09-30 | $0 |
| 2011-06-30 | $0 |
| 2011-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.008B | $0.002B |
| Axe Compute Inc. is engaged in using artificial intelligence and machine learning to expedite early drug discovery and enable drug development for the benefit of cancer patients. Axe Compute Inc., formerly known as Predictive Oncology Inc., is based in PITTSBURGH, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $114.495B | 24.87 |
| Cardinal Health (CAH) | United States | $51.955B | 22.98 |
| Becton Dickinson (BDX) | United States | $50.083B | 12.65 |
| West Pharmaceutical Services (WST) | United States | $18.021B | 34.36 |
| Cooper (COO) | United States | $16.264B | 20.09 |
| Align Technology (ALGN) | United States | $13.401B | 22.75 |
| Henry Schein (HSIC) | United States | $9.205B | 16.22 |
| Merit Medical Systems (MMSI) | United States | $4.842B | 23.81 |
| DENTSPLY SIRONA (XRAY) | United States | $2.583B | 8.20 |
| CONMED (CNMD) | United States | $1.294B | 9.07 |
| STAAR Surgical (STAA) | United States | $0.801B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.127B | 15.07 |
| Lifevantage (LFVN) | United States | $0.064B | 6.62 |